Skylight Health to Present at Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a...
Year: 2021
Coya Therapeutics™ Announces the Appointment of Hideki Garren, M.D., Ph.D., and Dov Goldstein, M.D., to Its Board of Directors
HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous...
Zymergen Announces Launch of Initial Public Offering
EMERYVILLE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced...
CENTOGENE Extends Partnership With Takeda
CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused...
Tauriga Sciences Inc. Confirms Substantial Pre-Orders for its 25mg CBD & CBG Infused Tauri-Gum
Tauriga 04-14-2021 Pomegranate Blister Pack Design: 25mg CBD Tauri-Gum™ NEW YORK, NY, April 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...
Vascular Biogenics Ltd. Closes Public Offering of Ordinary Shares and Pre-Funded Warrants
TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today...
Highlight to present Phase 2 data at AACR
Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual...
GN Store Nord upgrades financial guidance for 2021
GN Audio upgrades 2021 financial guidance following an extraordinarily strong start to 2021GN Hearing confirms 2021 financial guidanceGN Store Nord...
Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai
Press Release 14 April 2021 Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai Immunicum...
CORRECTION – VectivBio Announces Closing of $146.6 Million Initial Public Offering
BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by...
Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing Belapectin, Galectin Therapeutics’ Galectin-3 Inhibitor, Enhances Tumor Response in Combination with Anti-PD-1 Therapy
Combination therapy with belapectin suggests a better objective response rate with fewer adverse events than pembrolizumab (KEYTRUDA®) aloneNORCROSS, Ga., April...
Capital Senior Living Completes Third Round of COVID-19 Vaccinations at All Communities and Reports March Occupancy
DALLAS, April 13, 2021 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU) has completed first, second and third rounds of COVID-19 vaccinations at all its communities. To...
BIOPHYTIS Identifies False Report Regarding COVA study
PARIS and CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- BIOPHYTIS SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology...
eClinicalWorks’ Solution Helping Providers Schedule COVID-19 Appointments and Administer Vaccines Across 29 States
eClinicalWorks' Vaccine Administration Management Solution aids healthcare providers with efficient, effective, and HIPAA-compliant COVID-19 vaccine distribution WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, a...
NEW PUBLICATION: Rothman Index Provides New Approach to Triage for COVID-19 Patients at Hospital Admission
Unique predictive analytics tool may offer new insights into COVID-19 patient risk CHARLOTTE, N.C.--(BUSINESS WIRE)--#COVID19--The journal, Critical Care Explorations, has...
Establishment Labs to Announce First Quarter 2021 Financial Results on May 5
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the...
Can B Corp. Announces Full Year 2020 Results
Strong Gross Margin of 84% Efficiencies and Lower Expenses Lead to a Significant Reduction in Operating Loss HICKSVILLE, NY / ACCESSWIRE...
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
Cytisinicline Up to Five Times More Likely to Result in Smoking Abstinence Compared to Placebo Phase 3 ORCA-2 Trial Currently...
Hemogenyx Pharmaceuticals PLC Announces CDX Option Update
LONDON, UK / ACCESSWIRE / April 14, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and...
McDaid Pharmacy Is Working to Be a One-Stop Online Pharmacy for the Irish Market
CAVAN, IRELAND / ACCESSWIRE / April 14, 2021 / The Ireland-based pharmacy group has put together a robust online presence,...